|

BAR502 single dose Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • BAR Pharmaceuticals s.r.l.1

Indications

  • Liver Disease1
  • NASH1

Other1 trial

To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.